Search hospitals > New York > Rochester
Rochester Clinical Research, Inc
Claim this profileRochester, New York 14609
Global Leader in Vestibular Migraine
Global Leader in Migraine
Conducts research for Flu
Conducts research for Obesity
Conducts research for Childhood Obesity
245 reported clinical trials
8 medical researchers
Summary
Rochester Clinical Research, Inc is a medical facility located in Rochester, New York. This center is recognized for care of Vestibular Migraine, Migraine, Flu, Obesity, Childhood Obesity and other specialties. Rochester Clinical Research, Inc is involved with conducting 245 clinical trials across 226 conditions. There are 8 research doctors associated with this hospital, such as Matthew G Davis, MD, Patricia Lee, MD, Matthew Gilruth Davis, and Jonathan Goldstein.Top PIs
Matthew G Davis, MDGSK Investigational Site1 year of reported clinical research
Studies Respiratory Syncytial Virus Infection
Studies Respiratory Syncytial Virus
21 reported clinical trials
30 drugs studied
Patricia Lee, MDCenter for Clinical Studies4 years of reported clinical research
Studies Dermatitis and Eczema
Studies Atopic Dermatitis
9 reported clinical trials
10 drugs studied
Matthew Gilruth DavisRochester Clinical Research, Inc.5 years of reported clinical research
Studies Obesity
Studies Migraine
5 reported clinical trials
4 drugs studied
Jonathan GoldsteinRochester Clinical Research3 years of reported clinical research
Studies Ulcerative Colitis
Studies Colitis
5 reported clinical trials
3 drugs studied
Clinical Trials running at Rochester Clinical Research, Inc
Obesity
Childhood Obesity
High Blood Pressure
Vestibular Migraine
Migraine
Coronavirus
COVID-19
Cerebral Amyloid Angiopathy
Type 2 Diabetes
Psychogenic Colitis
Maridebart Cafraglutide
for Obesity
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.
Recruiting1 award Phase 32 criteria
Orforglipron
for High Blood Pressure
GZL1 is an independent study conducted under the GZPL master protocol. GZL1 will evaluate the efficacy and safety of orforglipron for treatment of hypertension in participants with obesity or overweight.
Recruiting1 award Phase 3
LY3305677
for Obesity
The purpose of this Phase-2 chronic weight management master protocol (CWMM) is to create a framework to evaluate the safety and efficacy of various investigational interventions for chronic weight management with intervention-specific appendices (ISAs). The CWMM establishes entry criteria for newly enrolled participants across the master and the ISAs. The ISAs may start independently of other ISAs as interventions become available for clinical testing. The results for the CWMM screening record will be reported when all the ISA's complete.
Recruiting0 awards Phase 23 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Rochester Clinical Research, Inc?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.